Certificate under SEBI (Depositories and Participants) Regulations, 2018

Date: 15th October, 2026 National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai- 400051. NSE SYMBOL: VAISHALI Subject: Certificate Under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018 for the period 01st July, 2026 to 30th September, 2026. Dear Sir, We hereby certify that the details of securities dematerialized / rematerialized during the Second Quarter ended 30th September, 2026 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 have been furnished to the Stock Exchange where the shares of the Company are listed. Kindly take the same on record. Thanking You, Yours Faithfully, For Vaishali Pharma Limited Vishwa Mekhia Company Secretary Cum Compliance Officer Ref No. BSS/SE-AU Date: 15/10/2026 VAISHALI PHARMA LIMITED_EQ NEW FV RS 2 INE972X01022 706-709,7TH FLR,R.C.PATEL ROAD ARAVALI BUSINESS CENTER OFF SODAWALA LANE,BORIVALI (W) MUMBAI 400092 Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026. Ref: NSDL/CIR/II/5/2019 dated 25th January 2019 DSL/OPS/RTA/POLICY/2019/14 dated 25th January 2019. SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24/01/2019 Dear Sir/Madam, With reference to the captioned regulation, we hereby confirm that the said Regulation is not applicable to the Company, as the entire holding of the Company’s shares are in demat form and we have not received any request from any members of the Company for rematerialisation or dematerialisation; during the quarter ended on 30th September 2026. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For Bigshare Services Pvt. Ltd., Sandeep More Authorised Signatory